Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,371 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $240.70 | 2 | $0 (2022) |
| Allergan Inc. | $211.80 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $142.82 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $125.00 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $123.17 | 1 | $0 (2018) |
| PFIZER INC. | $120.00 | 1 | $0 (2023) |
| Incyte Corporation | $119.75 | 1 | $0 (2022) |
| GENZYME CORPORATION | $112.73 | 1 | $0 (2020) |
| AcelRx Pharmaceuticals, Inc. | $98.16 | 1 | $0 (2020) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $77.34 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $262.82 | 2 | E.R. Squibb & Sons, L.L.C. ($142.82) |
| 2022 | $360.77 | 3 | Regeneron Healthcare Solutions, Inc. ($125.00) |
| 2020 | $210.89 | 2 | GENZYME CORPORATION ($112.73) |
| 2019 | $174.67 | 2 | Allergan Inc. ($97.33) |
| 2018 | $362.32 | 3 | AbbVie, Inc. ($124.68) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Inflammation & Immunology | ||||||
| 06/29/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $142.82 | General |
| Category: Immunology | ||||||
| 10/07/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $119.75 | General |
| Category: Dermatology | ||||||
| 05/11/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/03/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $116.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2020 | AcelRx Pharmaceuticals, Inc. | DSUVIA (Drug) | Food and Beverage | In-kind items and services | $98.16 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/04/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $112.73 | General |
| Category: Immunology | ||||||
| 03/02/2019 | Allergan Inc. | BOTOX COSMETIC | Food and Beverage | In-kind items and services | $97.33 | General |
| 03/02/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $77.34 | General |
| 03/08/2018 | Janssen Scientific Affairs, LLC | Tremfya (Drug) | Food and Beverage | In-kind items and services | $123.17 | General |
| Category: Immunology | ||||||
| 02/16/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $114.47 | General |
| 01/10/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $124.68 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 972 | 1,814 | $168,799 | $54,306 |
| 2022 | 15 | 1,198 | 2,101 | $179,751 | $59,860 |
| 2021 | 14 | 1,082 | 1,895 | $161,886 | $56,981 |
| 2020 | 11 | 697 | 1,147 | $90,918 | $30,243 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 314 | $39,685 | $20,554 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 180 | 217 | $19,121 | $9,305 | 48.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 130 | 173 | $16,538 | $5,864 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $6,502 | $3,271 | 50.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 32 | 45 | $12,713 | $3,205 | 25.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 59 | 66 | $8,383 | $2,943 | 35.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 98 | 125 | $23,450 | $2,453 | 10.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 34 | $14,350 | $2,398 | 16.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 65 | $6,825 | $1,054 | 15.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $1,974 | $1,032 | 52.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 108 | 677 | $15,151 | $969.72 | 6.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 24 | $2,116 | $659.92 | 31.2% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 17 | $1,992 | $596.39 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 287 | $26,108 | $17,257 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 229 | 270 | $15,616 | $10,254 | 65.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 158 | 212 | $20,372 | $7,441 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 90 | 90 | $13,320 | $7,419 | 55.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 67 | 78 | $9,891 | $3,263 | 33.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 47 | 59 | $16,807 | $3,239 | 19.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 119 | 137 | $25,670 | $2,521 | 9.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $3,315 | $2,238 | 67.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 18 | 36 | $15,194 | $1,964 | 12.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 43 | 75 | $7,875 | $1,194 | 15.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 119 | 753 | $17,819 | $1,114 | 6.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 20 | 25 | $2,204 | $756.78 | 34.3% |
About Dr. Shelly Rivas, M.D
Dr. Shelly Rivas, M.D is a Dermatology healthcare provider based in Vestal, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1477999886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shelly Rivas, M.D has received a total of $1,371 in payments from pharmaceutical and medical device companies, with $262.82 received in 2023. These payments were reported across 12 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,371).
As a Medicare-enrolled provider, Rivas has provided services to 3,949 Medicare beneficiaries, totaling 6,957 services with total Medicare billing of $201,391. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Vestal, NY
- Active Since 05/13/2013
- Last Updated 03/05/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1477999886
Products in Payments
- DUPIXENT (Biological) $237.73
- Sotyktu (Drug) $142.82
- Humira (Biological) $124.68
- Tremfya (Drug) $123.17
- CIBINQO (Drug) $120.00
- OPZELURA (Drug) $119.75
- SKYRIZI (Biological) $116.02
- DSUVIA (Drug) $98.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Vestal
Dr. Joseph Newmark, M.d, M.D
Dermatology — Payments: $12,315
Dr. Colleen Crandell, D.o, D.O
Dermatology — Payments: $5,503
Romeo Morales, Md, MD
Dermatology — Payments: $3,061
Ayyaz Shah, Do, DO
Dermatology — Payments: $1,617
Dr. Uzoma Oranu, M.d, M.D
Dermatology — Payments: $992.30
Catalina Dailey, Fnp-C, FNP-C
Dermatology — Payments: $427.62